Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
AssigneeFood Industry Research and Development Institute
InventorsSiao-Jhen Cheng, Yen-Lin Chen, Hsun-Yin Hsu, Kai-Ping Chen, Chiao-Ming Liao, Yi-Jen Yech
Life of this patent
Estimating the term…
Abstract
A method for inhibiting xanthine oxidase and for reducing uric acid levels using a pharmaceutical composition or a food product obtained by culturing Gluconacetobacter hansenii or Acetobacter pasteurianus in a medium. Also disclosed is a pharmaceutical composition and a food product that each include a metabolite of Gluconacetobacter hansenii or Acetobacter pasteurianus for reducing uric acid levels in a subject and methods for producing the pharmaceutical composition and the food product.
Claims15
A pharmaceutical composition for reducing uric acid levels in a subject, the composition comprising dextrin and a culture of an acetic acid bacteria in a medium that contains glucose, soy peptone, and yeast extract, wherein the acetic acid bacteria is Acetobacter pasteurianus strain AHU01, deposited under Accession No. DSM 28893, and the pharmaceutical composition is in lyophilized form.
A food product for reducing uric acid levels in a subject, the food product comprising in lyophilized form an acetic acid bacteria and dextrin, wherein the acetic acid bacteria is Acetobacter pasteurianus strain AHU01, deposited under Accession No. DSM 28893, and the food product is a vinegar, a health drink, a yogurt, a beverage, an ice cream, sour milk, or a cheese.
Dependencies are inferred from the claim text.